CommercialPrior AuthMedium impact
06.03.04o, Apheresis Therapy
Independence Blue Cross·Hematology, Oncology, Nephrology +2 more·Medical Policy
Effective date
Mar 17, 2025
We identified it
Jun 19, 2026
Summary
Policy 06.03.04o on Apheresis Therapy has been updated with revised medical necessity criteria, effective March 17, 2025. The billing team must review the new medical necessity requirements and implement any changes to prior authorization processes, documentation requirements, or coverage determinations for apheresis procedures.
Action Required
By March 17, 2025: Billing team and clinical staff must obtain and review the full policy text at the provided URL to identify specific medical necessity criteria changes. Update prior authorization workflows, clinical documentation templates, and billing system rules as needed to reflect new criteria. Communicate updated requirements to providers and front desk staff. Ensure all apheresis claims submitted after the effective date comply with revised medical necessity standards or they will be denied.